NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

噴射器市場:2020-2026

Jet Injector Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品編碼 1008059
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
噴射器市場:2020-2026 Jet Injector Market 2020-2026
出版日期: 2021年03月31日內容資訊: 英文
簡介

預計在預測期內,全球射流噴射器市場將以顯著的複合年增長率增長。噴射注射器或無針設備是在高壓下輸送流體的醫療設備,用於疫苗接種和藥物輸送。市場增長的主要驅動力是對最先進的藥物輸送技術的需求,尤其是糖尿病和癌症等慢性病患病率的增加。

此外,對自我注射設備的需求增加,降低交叉污染、無患者設備等風險,以及 FDA 和政府對無針噴射注射器的批准也對市場增長做出了重大貢獻。除此之外,針對正在進行的 COVID-19 大流行的疫苗接種預計將重振市場。例如,Codagenix 的鼻內 COVID-19 疫苗不需要針頭。

然而,某些因素正在影響市場的增長。高昂的開發成本和確保系統無菌的需求是全球噴射注射器市場增長的主要製約因素。相反,與生物仿製藥產品需求相關的技術進步和醫療保健成本上升是預測期內市場增長的機會。

本報告調查了噴射器市場,並提供了市場概況,以及進入市場的公司的類型、應用、技術、最終用戶、地區和概況的趨勢。

目錄

第 1 章報告概述

第 2 章市場概覽和洞察

  • 調查範圍
  • 分析師洞察和當前市場趨勢

第 3 章競爭形勢

  • 公司股票分析
  • 主要戰略分析
  • 主要公司分析
    • 概述
    • 財務分析
    • SWOT 分析
    • 近期發展

第 4 章市場決定因素

  • 動力
  • 抑制因素
  • 市場機會

第 5 章市場細分

  • 全球射流注射器市場,按產品類型
    • 預充式無針注射器
    • 可再充裝無針注射器
  • 全球射流注射器市場,按應用
    • 胰島素輸送
    • 呼吸系統疾病
    • 疫苗交付
    • 其他(腫瘤學)
  • 按技術分列的全球射流噴射器市場
    • 噴氣底座
    • 彈簧底座
    • 激光電源底座
    • 振動底座
  • 按最終用戶劃分的全球射流注射器市場
    • 製藥公司
    • 醫院和臨床中心
    • 其他

第六章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他領域

第 7 章公司簡介

  • AKRADERMOJET
  • Becton, Dickinson, and Co.
  • European Pharma Group BV
  • CODAGENIX, Inc.
  • Crossject SA
  • INJEX Pharma GmbH
  • Ferring Pharmaceuticals Inc.
  • Enesi Pharma Ltd.
  • Medical International Technology, Inc.
  • Merck KGaA
  • Inovio Pharmaceuticals Inc.
  • PharmaJet, Inc.
  • Mylan NV
  • Spirit Health Group Ltd.
  • Zealand Pharma AS
  • LEO Pharma Inc.
  • Portal Instruments, Inc.
目錄
Product Code: OMR2023352

Global Jet Injector Market Size, Share & Trends Analysis Report by Product (Prefilled Needle-Free Injectors and Fillable Needle-Free Injectors), By Application (Insulin Delivery, Respiratory Delivery, Vaccine Delivery, and Others), By Technology (Jet Based, Spring Based, Laser Power Based and Vibration Based), By End-User (Pharmaceutical Companies, Hospital & Clinical Centers and Others)

The global Jet Injector market is growing at a considerable CAGR during the forecast period. The jet injector or needle-free device is a medical device that is used for vaccination and drug delivery by the high-pressure narrow jet of fluid. The major factors that are augmenting the growth of the market include the need for modern technologies in drug delivery technology, the growing prevalence of chronic diseases such as diabetes and cancer among others.

Furthermore, increasing demand for self-injection devices, reduction in risks such as cross-contamination, pain-free devices for patients, and various FDA and government approvals for the needle-free jet injectors are also estimated to be the major factors that are contributing significantly towards the growth of the market. In addition to this, the vaccination for the ongoing COVID-19 pandemic is expected to fuel the market. For Instance, Codagenix's intranasal COVID-19 vaccine does not require the needle to be administered.

However, certain factors are affecting the growth of the market. High development cost, and the need to ensure system sterility are the major constraints that will challenge the growth of the jet injector market across the globe. Conversely, technological advancement and rise in healthcare expenditures with the demand for biosimilar products are opportunities for the market to grow in the forecast period.

Segmental Outlook

The market is segmented on the basis of product, application, technology, and end-user. By product, the market is segmented into prefilled needle-free injectors and fillable needle-free injectors. Based on the application segment, the market is segmented into insulin delivery, respiratory diseases, vaccine delivery, and others. Insulin delivery is expected to hold a major market share during the forecast period. The market growth is mainly driven by the rise in diabetes across the globe. According to the International Diabetes Federation (IDF), 463 million people globally have diabetes and the low-and middle-income countries are affected more. Moreover, it is one of the leading causes of mortalities across the globe as around 1.6 million mortalities are due to diabetes each year. Therefore, the market is estimated to grow even more in the forecast period due to the rise of the geriatric population.

Further, based on the technology segment, the market is segmented into jet-based, spring-based, laser power-based, and vibration-based. In addition to this, based on the end-user segment, the market is segmented into pharmaceutical companies, hospitals, and clinical centers, and others.

Global Jet Injector Share by Application, 2020 (%)

Source: OMR Global

Regional Outlooks

The global jet injector market is analyzed on the basis of the geographical regions that are contributing significantly to the growth of the market. On the basis of geography, the market is divided into North America, Europe, Asia Pacific, and the Rest of the World. North America is estimated to be one of the leading regions in the global jet injector market. Rising demand for self-administration healthcare facilities, mergers, and acquisitions by major players, rise in chronic diseases such as diabetes and cancer, and technological advancement are the major factors that fuel the market growth in North America. The US accounts for a major share in this region. Asia Pacific is estimated to be one of the fastest-growing regions during the forecast period. The rise in diabetes patients in the countries including India and China and the increase in government funding in this region are the factors that will grow the market in the forecast period. For instance, according to the International Diabetes Federation (IDF), 88 million people had diabetes in the Southeast Asia region out of which 77 million people were of India.

Global Jet Injector Market Growth, by Region 2021-2027

Source: OMR Global

Market Players Outlook

The jet injector market is fragmented however some players are actively contributing to the market. Key players of the jet injector market include European Pharma Group BV, Crossject SA, INJEX Pharma GmbH, and Pharmajet. In order to survive in the market, these players adopt different marketing strategies such as a merger, acquisitions, product launch, and geographical expansion so on.

The Report Covers

Market value data analysis of 2019 and forecast to 2026.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global female infertility diagnosis and treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market-entry and market expansion strategies.

Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Jet Injectors Market, By Product Type
    • 5.1.1. Prefilled Needle-Free Injectors
    • 5.1.2. Fillable Needle-Free Injectors
  • 5.2. Global Jet Injectors Market, By Application
    • 5.2.1. Insulin Delivery
    • 5.2.2. Respiratory Diseases
    • 5.2.3. Vaccine Delivery
    • 5.2.4. Others (Oncology)
  • 5.3. Global Jet Injectors Market, By Technology
    • 5.3.1. Jet Based
    • 5.3.2. Spring Based
    • 5.3.3. Laser Power Based
    • 5.3.4. Vibration Based
  • 5.4. Global Jet Injectors Market, By End-User
    • 5.4.1. Pharmaceutical Companies
    • 5.4.2. Hospital & Clinical Centres
    • 5.4.3. Others

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. AKRADERMOJET
  • 7.2. Becton, Dickinson, and Co.
  • 7.3. European Pharma Group BV
  • 7.4. CODAGENIX, Inc.
  • 7.5. Crossject SA
  • 7.6. INJEX Pharma GmbH
  • 7.7. Ferring Pharmaceuticals Inc.
  • 7.8. Enesi Pharma Ltd.
  • 7.9. Medical International Technology, Inc.
  • 7.10. Merck KGaA
  • 7.11. Inovio Pharmaceuticals Inc.
  • 7.12. PharmaJet, Inc.
  • 7.13. Mylan NV
  • 7.14. Spirit Health Group Ltd.
  • 7.15. Zealand Pharma AS
  • 7.16. LEO Pharma Inc.
  • 7.17. Portal Instruments, Inc.

LIST OF TABLES

  • 1. GLOBAL JET INJECTORS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027($ MILLION)
  • 2. GLOBAL PREFILLED NEEDLE FREE INJECTORS MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLION)
  • 3. GLOBAL FILLABLE NEEDLE FREE INJECTORS MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLION)
  • 4. GLOBAL JET INJECTORS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027($ MILLION)
  • 5. GLOBAL INSULIN DELIVERY MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLION)
  • 6. GLOBAL RESPIRATORY DISEASE MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLION)
  • 7. GLOBAL VACCINE-DELIVERY MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLION)
  • 8. GLOBAL OTHER APPLICATION MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLION)
  • 9. GLOBAL JET INJECTORS MARKET RESEARCH AND ANALYSIS BY SITE OF DELIVERY, 2020-2027($ MILLION)
  • 10. GLOBAL INTRAMUSCULAR MARKET RESEARCH AND ANALYSIS 2020-2027($ MILLION)
  • 11. GLOBAL INTRADERMAL MARKET RESEARCH AND ANALYSIS 2020-2027($ MILLION)
  • 12. GLOBAL JET INJECTORS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027($ MILLION)
  • 13. GLOBAL JET-BASED MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLION)
  • 14. GLOBAL SPRING-BASED MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLION)
  • 15. GLOBAL LASER POWER-BASED MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLION)
  • 16. GLOBAL VIBRATION-BASED MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLION)
  • 17. GLOBAL JET INJECTORS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027($ MILLION)
  • 18. GLOBAL PHARMACEUTICAL COMPANIES MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLION)
  • 19. GLOBAL HOSPITAL & CLINICAL CENTERS MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLION)
  • 20. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLION)
  • 21. NORTH AMERICA JET INJECTORS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027($ MILLION)
  • 22. NORTH AMERICA JET INJECTORS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027($ MILLION)
  • 23. NORTH AMERICA JET INJECTORS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027($ MILLION)
  • 24. NORTH AMERICA JET INJECTORS MARKET RESEARCH AND ANALYSIS BY SITE OF DELIVERY, 2020-2027($ MILLION)
  • 25. NORTH AMERICA JET INJECTORS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027($ MILLION)
  • 26. NORTH AMERICA JET INJECTORS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027($ MILLION)
  • 27. EUROPE JET INJECTORS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027($ MILLION)
  • 28. EUROPE JET INJECTORS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027($ MILLION)
  • 29. EUROPE JET INJECTORS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027($ MILLION)
  • 30. EUROPE JET INJECTORS MARKET RESEARCH AND ANALYSIS BY SITE OF DELIVERY, 2020-2027($ MILLION)
  • 31. EUROPE JET INJECTORS MARKET RESEARCH AND ANALYSIS BY INSTRUMENT, 2020-2027($ MILLION)
  • 32. EUROPE JET INJECTORS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027($ MILLION)
  • 33. ASIA PACIFIC JET INJECTORS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027($ MILLION)
  • 34. ASIA PACIFIC JET INJECTORS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027($ MILLION)
  • 35. ASIA PACIFIC JET INJECTORS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027($ MILLION)
  • 36. ASIA PACIFIC JET INJECTORS MARKET RESEARCH AND ANALYSIS BY SITE OF DELIVERY, 2020-2027($ MILLION)
  • 37. ASIA PACIFIC JET INJECTORS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027($ MILLION)
  • 38. ASIA PACIFIC JET INJECTORS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027($ MILLION)
  • 39. REST OF THE WORLD JET INJECTORS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027($ MILLION)
  • 40. REST OF THE WORLD JET INJECTORS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027($ MILLION)
  • 41. REST OF THE WORLD JET INJECTORS MARKET RESEARCH AND ANALYSIS BY SITE OF DELIVERY, 2020-2027($ MILLION)
  • 42. REST OF THE WORLD JET INJECTORS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027($ MILLION)
  • 43. REST OF THE WORLD JET INJECTORS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL JET INJECTORS MARKET SHARE BY PRODUCT TYPE 2019 VS 2027(%)
  • 2. GLOBAL JET INJECTORS MARKET SHARE BY APPLICATION 2019 VS 2027(%)
  • 3. GLOBAL JET INJECTORS MARKET SHARE, BY SITE OF DELIVERY 2019 VS 2027(%)
  • 4. GLOBAL JET INJECTORS MARKET SHARE, BY TECHNOLOGY 2019 VS 2027(%)
  • 5. GLOBAL JET INJECTORS MARKET SHARE, BY END-USER 2019 VS 2027(%)
  • 6. GLOBAL JET INJECTORS MARKET SHARE, BY GEOGRAPHY 2019 VS 2027 (%)
  • 7. GLOBAL PREFILLED NEEDLE FREE JET INJECTORS MARKET SHARE, BY GEOGRAPHY 2019 VS 2027 (%)
  • 8. GLOBAL FILLABLE NEEDLE FREE JET INJECTORS MARKET SHARE, BY GEOGRAPHY 2019 VS 2027 (%)
  • 9. GLOBAL INSULIN DELIVERYJET INJECTORS MARKET SHARE, BY GEOGRAPHY 2019 VS 2027 (%)
  • 10. GLOBAL RESPIRATORY DISEASESJET INJECTORS MARKET SHARE, BY GEOGRAPHY 2019 VS 2027 (%)
  • 11. GLOBAL VACCINE DELIVERYJET INJECTORS MARKET SHARE, BY GEOGRAPHY 2019 VS 2027 (%)
  • 12. GLOBAL OTHERS JET INJECTORS MARKET SHARE, BY GEOGRAPHY 2019 VS 2027 (%)
  • 13. GLOBAL JET BASEDJET INJECTORS MARKET SHARE, BY GEOGRAPHY 2019 VS 2027 (%)
  • 14. GLOBAL SPRING BASEDJET INJECTORS MARKET SHARE, BY GEOGRAPHY 2019 VS 2027 (%)
  • 15. GLOBAL LASER POWER BASEDJET INJECTORS MARKET SHARE, BY GEOGRAPHY 2019 VS 2027 (%)
  • 16. GLOBAL VIBRATION BASEDJET INJECTORS MARKET SHARE, BY GEOGRAPHY 2019 VS 2027 (%)
  • 17. GLOBAL PHARMACEUTICAL COMPANIESJET INJECTORS MARKET SHARE, BY GEOGRAPHY 2019 VS 2027 (%)
  • 18. GLOBAL HOSPITAL & CLINICAL CENTRESJET INJECTORS MARKET SHARE, BY GEOGRAPHY 2019 VS 2027 (%)
  • 19. GLOBAL OTHERS JET INJECTORS MARKET SHARE, BY GEOGRAPHY 2019 VS 2027 (%)
  • 20. NORTH AMERICA JET INJECTORS MARKET SIZE, 2020-2027($ MILLION)
  • 21. UNITED STATES JET INJECTORS MARKET R SIZE,2020-2027($ MILLION)
  • 22. CANADA JET INJECTORS MARKET SIZE,2020-2027($ MILLION)
  • 23. EUROPE JET INJECTORS MARKET SIZE, 2020-2027 ($ MILLION)
  • 24. UK JET INJECTORS MARKET SIZE, 2020-2027 ($ MILLION)
  • 25. GERMANY JET INJECTORS MARKET SIZE, 2020-2027 ($ MILLION)
  • 26. SPAIN JET INJECTORS MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. FRANCE JET INJECTORS SIZE, 2020-2027 ($ MILLION)
  • 28. ITALY JET INJECTORS MARKET SIZE, 2020-2027 ($ MILLION)
  • 29. REST OF EUROPE JET INJECTORS MARKET SIZE, 2020-2027 ($ MILLION)
  • 30. ASIA PACIFIC REGION JET INJECTORS MARKET SIZE, 2020-2027 ($ MILLION)
  • 31. INDIA JET INJECTORS MARKET SIZE, 2020-2027 ($ MILLION)
  • 32. CHINA JET INJECTORS MARKET SIZE, 2020-2027 ($ MILLION)
  • 33. JAPAN JET INJECTORS MARKET SIZE, 2020-2027 ($ MILLION)
  • 34. REST OF ASIA PACIFIC REGION JET INJECTORS MARKET SIZE, 2020-2027 ($ MILLION)
  • 35. REST OF THE WORLD JET INJECTORS MARKET SIZE, 2020-2027 ($ MILLION)